Antev Ltd.

Pipeline

Market Indications Pre-Clinical Phase I Phase II Phase III
Prostate Cancer
(NCT07457164)
Phase IIb Ongoing
Acute Urinary Retention
(NCT07733934)
Phase IIb Ongoing